You are here:

levetiracetam (Keppra®) 750 mg tablets


Following an abbreviated submission

Levetiracetam 750 mg film coated tablets are accepted for restricted use in NHS Scotland as an additional dosage form for adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in patients for whom therapy is appropriate. Its use should be initiated by physicians who have appropriate experience in the treatment of epilepsy. The budget impact for NHS Scotland is likely to be small.

Drug Details

Drug Name: levetiracetam (Keppra®) 750 mg tablets
SMC Drug ID: 150/04
Manufacturer: UCB Pharma Ltd
Indication: Epilepsy
BNF Category:
Sub Category: 4.8 Antiepileptic drugs
Submission Type: Abbreviated Submission
Status: Restricted
Date Advice Published: 10 January 2005